Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic Mechanisms of Promigratory Chemokine CXCL14 Regulation in Human Prostate Cancer Cells
Eun Young Song, Michael R. Shurin, Irina L. Tourkova, et al.
Cancer Research (2010) Vol. 70, Iss. 11, pp. 4394-4401
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

The chemokine system and cancer
Frances R. Balkwill
The Journal of Pathology (2011) Vol. 226, Iss. 2, pp. 148-157
Open Access | Times Cited: 386
Epigenetic Regulation of Inflammatory Cytokines and Associated Genes in Human Malignancies
Rehana Yasmin, Sami Siraj, Amjad Hassan, et al.
Mediators of Inflammation (2015) Vol. 2015, pp. 1-8
Open Access | Times Cited: 109
Suppression of Antitumor Immune Responses by Human Papillomavirus through Epigenetic Downregulation of CXCL14
Louis Cicchini, Joseph A. Westrich, Tao Xu, et al.
mBio (2016) Vol. 7, Iss. 3
Open Access | Times Cited: 107
Dietary Phytochemicals and Cancer Chemoprevention: A Perspective on Oxidative Stress, Inflammation, and Epigenetics
Wenji Li, Yue Guo, Chengyue Zhang, et al.
Chemical Research in Toxicology (2016) Vol. 29, Iss. 12, pp. 2071-2095
Closed Access | Times Cited: 88
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses
Joseph A. Westrich, Daniel W. Vermeer, Paul L. Colbert, et al.
Molecular Carcinogenesis (2020) Vol. 59, Iss. 7, pp. 794-806
Open Access | Times Cited: 88
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
Amer M. Zeidan, Isaac W. Boss, C.L. Beach, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2219-2229
Open Access | Times Cited: 65
CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects
Lei Tang, Xin Chen, Jianquan Hou, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Chemokine CXCL14; a double-edged sword in cancer development
Arezoo Gowhari Shabgah, Zahraa Haleem Al‐qaim, Alexander Markov, et al.
International Immunopharmacology (2021) Vol. 97, pp. 107681-107681
Closed Access | Times Cited: 51
Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals
Takahiko Hara, K. Tanegashima
The Journal of Biochemistry (2012) Vol. 151, Iss. 5, pp. 469-476
Open Access | Times Cited: 74
Expression of CXCL14 and its anticancer role in breast cancer
Xiao-Li Gu, Zhou-Luo Ou, Feng-Juan Lin, et al.
Breast Cancer Research and Treatment (2012) Vol. 135, Iss. 3, pp. 725-735
Closed Access | Times Cited: 61
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes
Amer M. Zeidan, Isaac W. Boss, C.L. Beach, et al.
Blood Advances (2021) Vol. 6, Iss. 7, pp. 2207-2218
Open Access | Times Cited: 36
Global hypomethylation and promoter methylation in small intestinal neuroendocrine tumors
Omid Fotouhi, Maral Adel Fahmideh, Magnus Kjellman, et al.
Epigenetics (2014) Vol. 9, Iss. 7, pp. 987-997
Open Access | Times Cited: 51
CXCL14 antagonizes the CXCL12-CXCR4 signaling axis
Takahiko Hara, Kosuke Tanegashima
BioMolecular Concepts (2014) Vol. 5, Iss. 2, pp. 167-173
Open Access | Times Cited: 45
Suppressed rate of carcinogenesis and decreases in tumour volume and lung metastasis in CXCL14/BRAK transgenic mice
Ryu‐Ichiro Hata, Kazuhito Izukuri, Yukio Kato, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 43
Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma
Anuraag S. Parikh, JuneHo Shin, William C. Faquin, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001048-e001048
Open Access | Times Cited: 37
CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems
Ariadni Kouzeli, Paul J. Collins, Mieke Metzemaekers, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 33
Crosstalk Between Inflammatory Signaling and Methylation in Cancer
Dipanwita Das, Nandini Karthik, Reshma Taneja
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 30
Epigenetic Perspective of Immunotherapy for Cancers
Sunita Keshari, Praveen Barrodia, Anand K. Singh
Cells (2023) Vol. 12, Iss. 3, pp. 365-365
Open Access | Times Cited: 12
The Chemokine CXCL14 as a Potential Immunotherapeutic Agent for Cancer Therapy
Nicholas S. Giacobbi, Shreya Mullapudi, Harrison Nabors, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 302-302
Open Access | Times Cited: 4
Antitumor efficacy of C‐X‐C motif chemokine ligand 14 in hepatocellular carcinoma in vitro and in vivo
Weilin Wang, Pengfei Huang, Lufei Zhang, et al.
Cancer Science (2013) Vol. 104, Iss. 11, pp. 1523-1531
Open Access | Times Cited: 42
Epigenetic silencing of CXCL14 induced colorectal cancer migration and invasion.
Baoping Cao, Yunsheng Yang, Yuanming Pan, et al.
PubMed (2013)
Closed Access | Times Cited: 39
Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
Harriet Wikman, Laura P. Westphal, Felicitas Schmid, et al.
Oncotarget (2014) Vol. 5, Iss. 10, pp. 3076-3087
Open Access | Times Cited: 36
Regulation of Chemokine Expression in the Tumor Microenvironment
Anton V. Gorbachev, Robert L. Fairchild
Critical Reviews in Immunology (2014) Vol. 34, Iss. 2, pp. 103-120
Open Access | Times Cited: 35
The Fine Balance of Chemokines During Disease: Trafficking, Inflammation, and Homeostasis
Sandra M. Cardona, Jenny A. Garcia, Astrid E. Cardona
Methods in molecular biology (2013), pp. 1-16
Open Access | Times Cited: 34
Expression and effect of CXCL14 in colorectal carcinoma
Kezhi Lin, Ruanmin Zou, Feng Lin, et al.
Molecular Medicine Reports (2014) Vol. 10, Iss. 3, pp. 1561-1568
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top